HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.
Meeting News CoverageVideo

Age, preoperative size predicted subclinical spread of melanoma in situ treated with Mohs’ surgery

April 18, 2014
NEW YORK — In this video, Tuzar M. Shin, MD, PhD, presented data which indicated that a patient’s age and the preoperative size of…
Meeting News Coverage

Sentinel-node biopsy improved DFS, staging in melanoma

April 15, 2014
NEW YORK — Sentinel lymph node biopsy after wide excision improved DFS compared with wide excision alone among patients with intermediate and…
Meeting News Coverage

Sentinel-node biopsy improved DFS, staging in melanoma

HemOnc Today, May 25, 2014
NEW YORK — Sentinel lymph node biopsy after wide excision improved DFS compared with wide excision alone among patients with intermediate and…
Meeting News CoverageVideo

Therapy with vismodegib effective in locally advanced, metastatic basal cell carcinoma

April 14, 2014
NEW YORK — In this video, Rogerio I. Neves, MD, PhD, FACS, presents data from a single-center study in which the hedgehog inhibitor…
Meeting News Coverage

Sun exposure, family history guide risk assessment for melanoma screening

April 14, 2014
NEW YORK — Several factors can help better define individuals at high risk for melanoma, according to a presenter at the HemOnc Today Melanoma…
Meeting News Coverage

Age, preoperative size may predict subclinical spread of melanoma in situ

April 13, 2014
NEW YORK — A patient’s age and the preoperative size of lesions may help predict subclinical spread of melanoma in situ treated with…
Meeting News Coverage

T-VEC superior to GM-CSF for unresected, metastatic melanoma

April 12, 2014
NEW YORK — Secondary endpoint results from a multicenter, randomized phase 3 trial showed talimogene laherparepvec conferred greater benefit…
Meeting News Coverage

T-VEC superior to GM-CSF for unresected, metastatic melanoma

HemOnc Today, May 25, 2014
NEW YORK — Secondary endpoint results from a multicenter, randomized phase 3 trial showed talimogene laherparepvec conferred greater benefit…
Meeting News Coverage

Vismodegib effective in basal cell carcinoma

April 12, 2014
NEW YORK — The hedgehog inhibitor vismodegib demonstrated encouraging activity in patients with basal cell carcinoma, according to results of a…
Meeting News Coverage

Vismodegib effective in basal cell carcinoma

HemOnc Today, May 25, 2014
NEW YORK — The hedgehog inhibitor vismodegib demonstrated encouraging activity in patients with basal cell carcinoma, according to results of a…